Below is an \*\*A→Z structured guide\*\* you can literally follow as a blueprint for your Colab/Jupyter notebook and report.

You can think of this as your \*\*“final approach prompt”\*\* for the hackathon: it covers

\- preprocessing → modeling → training → evaluation → visualization → reasoning,

\- aligns with the \*\*BioFusion guidelines\*\*, 

\- uses \*\*ResNet50 \+ spatial logic\*\*, 

\- and includes \*\*AI engineer techniques\*\* (splits, CV, anti-overfitting, fine-tuning, etc.).

You can copy sections directly into markdown cells in your notebook.

\*\*\*

\#\# 0\. Project Title & One-Line Goal

\*\*Title (Notebook top):\*\* 

\`Gastric Cancer Tumor–Immune Microenvironment Analysis using ResNet50 and Spatial Logic\`

\*\*Goal (in markdown):\*\* 

\> We use a pretrained ResNet50 and a custom spatial reasoning layer to (1) classify gastric histopathology tiles into tissue types, (2) detect Tumor (TUM) and Lymphocyte (LYM) patches, and (3) compute tumor–immune interaction metrics (e.g., TIL score, Tumor–Stroma Ratio), with visual heatmaps and rigorous evaluation.

\*\*\*

\#\# 1\. Problem Definition (Markdown)

\`\`\`markdown

\# 1\. Problem Definition

\#\# 1.1 Clinical Context

Gastric cancer prognosis and response to immunotherapy depend heavily on the tumor microenvironment (TME), 

especially on:

\- how much tumor tissue is present,

\- how much stroma surrounds the tumor,

\- how many lymphocytes infiltrate the tumor (Tumor-Infiltrating Lymphocytes, TILs).

Manually quantifying these components on whole slide images is extremely time-consuming and subjective for pathologists.

\#\# 1.2 What We Predict

We aim to:

1\. Classify each 224×224 histopathology tile into one of the GCHTID tissue classes (TUM, LYM, STR, etc.).

2\. Focus on detecting:

\- TUM (Tumor epithelium)

\- LYM (Lymphocytes)

\- STR (Stroma)

3\. Compute quantitative metrics like:

\- Tumor–Stroma Ratio (TSR)

\- TIL-like score (fraction of LYM adjacent to TUM)

\#\# 1.3 Intended Impact

\- Provide an automated, reproducible way to quantify tumor–immune interactions.

\- Serve as a proof-of-concept that can later be validated on real hospital slides and integrated into digital pathology workflows.

\`\`\`

\*\*\*

\#\# 2\. Dataset Documentation (Markdown \+ Code)

\`\`\`markdown

\# 2\. Dataset Documentation (GCHTID)

Dataset: Gastric Cancer Histopathology Tissue Image Dataset (GCHTID) 

Source: Kaggle (mirrors the Figshare/Nature Scientific Data release) 

Images: 31,096 tiles, 224×224 RGB 

Classes (original paper):

\- ADI: Adipose

\- BACK: Background

\- DEB: Debris

\- LYM: Lymphocytes

\- MUC: Mucus

\- MUS: Smooth Muscle

\- NORM: Normal mucosa

\- STR: Cancer-associated Stroma

\- TUM: Tumor epithelium

We will use these labels as-is, but will emphasize TUM, LYM, and STR for downstream clinical metrics (TSR, TIL-like score).

We will:

\- verify class distribution,

\- check for class imbalance,

\- design loss/metrics accordingly (e.g., focal loss, class weights).

\`\`\`

\*\*Code outline (Python):\*\*

\- Read image paths and labels.

\- Compute class counts and plot bar chart.

\*\*\*

\#\# 3\. Data Splits & Validation Strategy (Train/Val/Test \+ Cross-Validation)

\`\`\`markdown

\# 3\. Data Splitting and Validation Strategy

To prevent data leakage and obtain honest estimates of generalization:

\- We split the dataset into:

\- 70% Training

\- 15% Validation

\- 15% Test

We ensure the split is \*\*stratified\*\* by class so each set preserves the overall class distribution.

We also perform \*\*k-fold cross-validation (optional)\*\* on the training set (e.g., k=3) for:

\- robust hyperparameter tuning,

\- more stable performance estimates.

We keep the \*\*test set completely untouched\*\* until the final evaluation step.

\`\`\`

\*\*AI engineer techniques:\*\*

\- Use \`StratifiedShuffleSplit\` (scikit-learn) or stratified split logic.

\- Fix random seeds for reproducibility.

\*\*\*

\#\# 4\. Preprocessing & Augmentation (With Reasoning)

\`\`\`markdown

\# 4\. Preprocessing and Data Augmentation

\#\# 4.1 Preprocessing

\- \*\*Resize\*\*: Images are already 224×224 → matches ResNet50 input.

\- \*\*Normalization\*\*: We normalize RGB channels with mean and std used for ImageNet:

\- mean \= \[0.485, 0.456, 0.406\]

\- std \= \[0.229, 0.224, 0.225\]

Rationale: 

Using ImageNet statistics aligns the input distribution with what the pretrained backbone expects, 

leading to faster convergence and more stable training.

\#\# 4.2 Data Augmentation

We apply the following on the training set only:

\- Random horizontal/vertical flips

\- Random rotations (e.g., ±90°)

\- Random brightness/contrast (mild)

Rationale:

\- Tissue orientation in histopathology is not fixed → model should be rotation and flip invariant.

\- Slight color jitter increases robustness to stain variation between labs.

\- We avoid aggressive warping that would distort cell morphology.

\`\`\`

\*\*\*

\#\# 5\. Model Initialization & Architecture (ResNet50 \+ New Head)

\`\`\`markdown

\# 5\. Model Initialization and Architecture

\#\# 5.1 Base Model Choice: ResNet50

We use a ResNet50 pretrained on ImageNet as our backbone.

Reasons:

\- Proven strong performance on medical image tasks.

\- Widely used and well-understood in research (transparent choice).

\- Efficient enough to train in Google Colab.

\- Convolutional layers extract local texture patterns important for histology.

\#\# 5.2 Transfer Learning Strategy

1\. Load pretrained ResNet50 (weights from ImageNet).

2\. Replace the final fully-connected layer with a new classifier:

\- Input: 2048-dim feature vector

\- Output: 9 classes (ADI, BACK, DEB, LYM, MUC, MUS, NORM, STR, TUM).

3\. Training phases:

\- Phase 1: Freeze all ResNet layers, train only the new classifier head.

\- Phase 2: Unfreeze top blocks (e.g., last 1–2 residual stages), fine-tune with a lower learning rate.

\- Phase 3 (optional): Unfreeze more layers if the validation metrics suggest underfitting.

Rationale:

\- Freezing early layers protects low-level features (edges, textures) that generalize well.

\- Fine-tuning deeper layers adapts high-level features from "natural objects" to "tissue patterns".

\- This balances \*\*stability\*\* and \*\*adaptation\*\*, avoiding overfitting on a relatively small dataset.

\`\`\`

\*\*\*

\#\# 6\. Loss Functions & Optimization (Math \+ Reasoning)

\`\`\`markdown

\# 6\. Loss Functions and Optimization

\#\# 6.1 Class Imbalance and Loss

We check the class distribution and find that some classes (e.g., DEB, MUC) are under-represented.

To handle imbalance, we use either:

\- \*\*Weighted Cross-Entropy Loss\*\* with class weights inversely proportional to class frequency, or

\- \*\*Focal Loss\*\*:

\\\[

FL(p\_t) \= \-\\alpha (1 \- p\_t)^\\gamma \\log(p\_t)

\\\]

We choose Focal Loss with γ \= 2.0 to down-weight easy examples and focus learning on hard, often minority-class samples.

\#\# 6.2 Optimizer and Learning Rate Schedule

\- Optimizer: AdamW or SGD with momentum.

\- Learning rate:

\- Head: 1e-3

\- Fine-tuned backbone layers: 1e-4 or 1e-5 (Layer-wise Learning Rate Decay).

Rationale:

\- Head needs larger updates (randomly initialized).

\- Pretrained layers need gentle updates to avoid catastrophic forgetting.

\`\`\`

\*\*\*

\#\# 7\. Training Loop, Anti-Overfitting Techniques

\`\`\`markdown

\# 7\. Training Strategy and Anti-Overfitting Measures

\#\# 7.1 Training Loop

For each epoch:

1\. Forward pass on training batch.

2\. Compute loss (Focal or Weighted Cross-Entropy).

3\. Backpropagate gradients.

4\. Optimizer step.

5\. Log training loss and metrics.

On validation set:

\- Compute loss and metrics without gradient updates.

\#\# 7.2 Anti-Overfitting Techniques

We use:

\- Data augmentation (Section 4.2).

\- Early stopping on validation loss or F1 score.

\- L2 regularization / weight decay (AdamW).

\- Dropout in the classifier head.

We monitor:

\- Training vs validation curves to detect overfitting.

\- Use patience (e.g., stop if no improvement in 5 epochs).

\`\`\`

You can also briefly mention:

\- Label smoothing (small epsilon, e.g., 0.1).

\- Optional MixUp/CutMix (if time permits).

\*\*\*

\#\# 8\. Evaluation Metrics & Math

\`\`\`markdown

\# 8\. Evaluation Metrics

We report:

\#\# 8.1 Per-Class Metrics

\- Precision, Recall, and F1-score per class.

\- Macro-averaged F1 (treats all classes equally).

\- Weighted F1 (weights by support).

\#\# 8.2 Confusion Matrix

We plot a 9×9 confusion matrix to visualize:

\- Which tissue types are most frequently confused.

\- Special attention on TUM vs STR vs LYM performance.

\#\# 8.3 Matthews Correlation Coefficient (MCC)

Since the dataset is imbalanced, we also compute MCC, which is robust to class imbalance and gives a single scalar between \-1 and \+1:

\\\[

MCC \= \\frac{TP \\times TN \- FP \\times FN}

{\\sqrt{(TP+FP)(TP+FN)(TN+FP)(TN+FN)}}

\\\]

For multiclass, we use the generalized MCC implementation.

\#\# 8.4 Confidence Intervals (Bootstrap)

To avoid overclaiming performance, we:

\- Bootstrap the test set (e.g., 1000 resamples),

\- Compute accuracy and F1 for each,

\- Report 95% confidence intervals (2.5th–97.5th percentile).

This provides a more statistically honest estimate of model performance.

\`\`\`

\*\*\*

\#\# 9\. Spatial Logic Layer (Neuro-Symbolic Part)

\`\`\`markdown

\# 9\. Spatial Reasoning Layer (Neuro-Symbolic AI)

The ResNet50 gives a prediction per tile independently. However, pathologists reason using \*\*context\*\*:

\- A tile is more likely tumor if surrounded by tumor.

\- A lymphocyte is clinically important if it is adjacent to tumor (Tumor-Infiltrating Lymphocyte, TIL).

We implement a post-processing \*\*Spatial Logic Layer\*\*:

\#\# 9.1 Majority Smoothing

Given a 2D grid of predicted labels (for tiles arranged on a synthetic slide):

\- For each tile, we look at its 3×3 neighborhood.

\- We replace the center label with the majority label in the window.

Rationale:

This reduces isolated misclassifications and reflects the fact that tissue types tend to be spatially coherent.

\#\# 9.2 TIL-like Detection (Adjacency Rule)

We define a TIL-like event as:

\- A tile predicted as LYM that has at least one neighboring tile predicted as TUM.

We compute:

\- TIL\_count \= number of LYM tiles adjacent to TUM tiles.

\- TUM\_count \= total TUM tiles.

We define a simple TIL-like score:

\\\[

TIL\\\_score \= \\frac{TIL\\\_count}{TUM\\\_count \+ \\epsilon}

\\\]

This approximates tumor-infiltrating lymphocyte density from tile predictions.

\#\# 9.3 Tumor–Stroma Ratio (TSR)

From tile predictions we compute:

\- STR\_count \= number of stromal (STR) tiles.

\- TUM\_count \= number of tumor (TUM) tiles.

\\\[

TSR \= \\frac{STR\\\_count}{STR\\\_count \+ TUM\\\_count \+ \\epsilon}

\\\]

High TSR has been associated with worse prognosis in several cancers.

These metrics illustrate how tile-level predictions translate into clinically meaningful TME quantification.

\`\`\`

\*\*\*

\#\# 10\. Visualizations (Charts & Heatmaps)

\`\`\`markdown

\# 10\. Visualizations

We provide multiple visual summaries:

\#\# 10.1 Class Distribution Plot

\- Bar chart of number of images per class.

\#\# 10.2 Training Curves

\- Line plots of training and validation loss over epochs.

\- Line plots of training and validation F1 over epochs.

\#\# 10.3 Confusion Matrix Heatmap

\- 9×9 heatmap (seaborn) of confusion matrix values.

\- Annotated with counts or normalized percentages.

\#\# 10.4 Embedding Visualization

\- Use t-SNE or UMAP on the penultimate layer features.

\- Color points by class label to see class separation in feature space.

\#\# 10.5 Synthetic Slide Heatmap

\- Arrange a grid of tiles.

\- For each tile, color it according to its predicted class (e.g., red for TUM, blue for LYM, green for STR).

\- Show:

\- Original tile grid,

\- Class color map,

\- TIL overlay (highlight LYM adjacent to TUM).

These visualizations help both ML judges and clinicians intuitively understand what the model does.

\`\`\`

You can include Grad-CAM for interpretability if time permits.

\*\*\*

\#\# 11\. Reproducibility & Notebook Structure

\`\`\`markdown

\# 11\. Reproducibility and Notebook Design

We ensure reproducibility by:

\- Setting random seeds for NumPy, Python, and the deep learning framework.

\- Using relative paths and documenting any required environment setup.

\- Structuring the notebook in logical sections matching this guide:

1\. Problem Definition

2\. Dataset Loading and Exploration

3\. Preprocessing and Augmentation

4\. Model Initialization (ResNet50)

5\. Training Loop Implementation

6\. Evaluation Metrics and Confusion Matrix

7\. Spatial Logic Layer (TIL & TSR)

8\. Visualizations (Curves, Heatmaps)

9\. Error Analysis and Limitations

10\. Conclusion and Future Work

We also save:

\- Final model weights (e.g., \`resnet50\_gchtid\_best.pt\`).

\- Key artifacts (confusion matrix, t-SNE plots, heatmaps).

\`\`\`

\*\*\*

\#\# 12\. Error Analysis, Limitations, Future Work (for Report)

\`\`\`markdown

\# 12\. Error Analysis, Limitations, and Future Work

\#\# 12.1 Error Analysis

\- Identify classes where F1 is low (e.g., MUC vs NORM confusion).

\- Show example tiles where the model fails and hypothesize why (e.g., poor staining, ambiguous morphology).

\#\# 12.2 Limitations

\- Training data comes from a single center (Harbin Medical University) → domain shift issue for other hospitals.

\- Tiles are not linked to individual patients/WSIs in the Kaggle version, limiting patient-level analysis.

\- Our TIL and TSR scores are approximate; they need clinical validation on real patient outcomes.

\#\# 12.3 Future Work

\- Fine-tune on hospital-specific WSIs with coordinate metadata.

\- Integrate stain normalization to handle inter-lab variability.

\- Extend model to predict molecular markers (e.g., MSI status) from morphology.

\`\`\`

\*\*\*

\#\# 13\. Final “Prompt” Summary (What Your Colab Does, Step-by-Step)

In very compact form (for yourself):

1\. Load GCHTID → inspect classes, plot distribution. 

2\. Stratified split into train/val/test. 

3\. Define transforms: normalize, augment (train only). 

4\. Load pretrained ResNet50, replace head → 9 classes. 

5\. Train with:

\- Weighted Cross-Entropy or Focal Loss 

\- AdamW, LR scheduling, early stopping 

6\. Evaluate on validation, tune hyperparams (batch size, LR, weight decay). 

7\. Final training on train+val (optional), test on test set once. 

8\. Compute:

\- Per-class Precision/Recall/F1 

\- MCC 

\- Confusion matrix 

\- Bootstrap CI for accuracy/F1 

9\. Build simple spatial grids (synthetic slides) from tiles, apply:

\- Majority smoothing 

\- TIL-score (LYM adjacent to TUM) 

\- TSR (STR vs TUM counts) 

10\. Plot:

\- Training curves 

\- CM heatmap 

\- t-SNE of features 

\- Synthetic heatmaps of TUM/LYM/STR 

11\. Document every step in markdown with reasoning (as above). 

If you structure your notebook and report along this skeleton, you will:

\- Satisfy the \*\*BioFusion\*\* guidelines line-by-line,

\- Demonstrate \*\*solid ML engineering\*\*,

\- And show \*\*clear medical reasoning\*\* behind every decision.

Sources

\[1\] Bio-Fusion-guideline.pdf https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/attachments/15628737/f24ba0f7-dd65-4103-9e01-466545809e8a/Bio-Fusion-guideline.pdf

